All the funding deals in the Brain-Computer interface market
In our updated market reports, you will find everything you need
The Brain-Computer interface market is attracting major investment across implantable devices, non-invasive systems, neuroprosthetics, and brain-signal software.
We conducted deep research and collected 28 Brain-Computer interface market funding deals announced between Q1 2024 and Q2 2026.
We refresh this Brain-Computer interface market page very often to add newly announced funding rounds.
Insights
- The 28 Brain-Computer interface market deals raised about $2.34 billion in total, showing that investors are making large bets on technologies that connect neural activity with external devices.
- Neuralink raised $650 million in Q2 2025. This single Brain-Computer interface funding round represented almost 28% of all capital collected in our dataset.
- The five largest Brain-Computer interface market deals accounted for about 69% of total funding, which shows that capital remains concentrated among a small group of advanced companies.
- Brain-Computer interface market funding increased from about $406 million in 2024 to almost $1 billion in 2025, supported by major rounds for Neuralink and Synchron.
- Brain-Computer interface companies raised about $933 million during the first half of 2026, bringing 2026 funding close to the total recorded during all of 2025.
- Q1 2026 was especially active for the Brain-Computer interface market. Six companies raised about $866 million during the quarter.
- The typical Brain-Computer interface funding round was much smaller than the largest deals. The median round in this dataset was about $19 million.
- Implantable Brain-Computer interface companies received many of the largest investments, but non-invasive systems also attracted significant rounds from BrainCo and Merge Labs.
- Vision restoration is becoming an important Brain-Computer interface market segment. Science Corporation and ReVision Implant raised capital for technologies designed to restore useful vision.
- Several Brain-Computer interface companies raised more than once during the period. Neurable, Subsense, and StairMed each announced separate funding rounds in different quarters.
Summary table of the funding deals for the Brain-Computer interface market since 2024
We define the Brain-Computer interface market as neurotechnology that records, interprets, or stimulates brain signals to control devices or restore function.
It includes Implantable BCIs, Non Invasive BCIs, Neuroprosthetics, Neural Signal Processing, BCI Software Platforms, and Clinical Neurotechnology.
It excludes broader adjacent markets unless the product is built specifically for this use case.
We focused exclusively on pure players, defined as companies with at least 70–80% of their business directly tied to the Brain-Computer interface market.
Our analysis has been done at a global level with a minimum funding threshold of $300k.
If you want a longer-term view, we also have a study of how funding activity in the Brain-Computer interface market has changed over the years.
| Name | What they do | Amount in $ | Quarter | Source(s) |
|---|---|---|---|---|
| Neurosoft Bioelectronics | Develops soft cortical electrodes for minimally invasive brain interfaces and neural data collection. | $7.5M | Q2 2026 | Business Wire |
| ReVision Implant | Develops a visual-cortex implant designed to restore useful vision without relying on the eyes. | $4.3M | Q2 2026 | Tech Funding News |
| Axoft | Develops soft implantable brain interfaces for high-resolution neural recording and brain-health applications. | $55.0M | Q2 2026 | Business Wire |
| Insellar | Develops a minimally invasive brain interface for treating severe treatment-resistant depression. | $0.45M | Q2 2026 | IBB Ventures |
| StairMed | Develops wireless implantable brain interfaces and robotic systems for neurosurgical procedures. | $72.7M | Q1 2026 | KrASIA |
| Gestala | Develops ultrasound brain interfaces for neural monitoring, stimulation, rehabilitation, and mental health treatments. | $21.6M | Q1 2026 | TNW |
| Science Corporation | Develops brain interfaces and retinal implants designed to restore vision for people with blindness. | $230.0M | Q1 2026 | Business Wire |
| Blue Arbor Technologies | Develops implanted nerve and muscle interfaces for controlling advanced robotic prostheses. | $5.0M | Q1 2026 | Business Wire |
| Merge Labs | Develops non-invasive brain interfaces using molecules and ultrasound for human and artificial intelligence interaction. | $250.0M | Q1 2026 | TechCrunch |
| BrainCo | Develops non-invasive brain interfaces and intelligent prosthetics for rehabilitation and device control. | $286.3M | Q1 2026 | Yicai Global |
| Neurable | Develops non-invasive brain-interface technology and neural software for consumer devices and wearables. | $35.0M | Q4 2025 | Business Wire |
| Subsense | Develops non-surgical brain-interface technology for treating neurodegenerative diseases. | $10.0M | Q4 2025 | Axios |
| Synchron | Develops an endovascular brain interface that converts brain activity into digital commands. | $200.0M | Q4 2025 | Business Wire |
| Coherence Neuro | Develops a therapeutic brain implant for monitoring and supporting cancer treatment. | $10.0M | Q4 2025 | MassDevice |
| Neuralink | Develops implantable brain interfaces that help people with paralysis control external devices. | $650.0M | Q2 2025 | Neuralink, El País |
| Phantom Neuro | Develops minimally invasive neural interfaces for controlling robotic prostheses and assistive devices. | $19.0M | Q2 2025 | PR Newswire |
| brain.space | Builds EEG headsets and machine-learning tools for interpreting cognitive and mental states. | $11.0M | Q1 2025 | PR Newswire |
| Subsense | Develops a non-surgical brain interface using nanoparticles to exchange signals with external systems. | $17.0M | Q1 2025 | BioSpace |
| StairMed Technology | Develops minimally invasive implanted brain interfaces for clinical and medical applications. | $47.9M | Q1 2025 | Yicai Global |
| Precision Neuroscience | Develops minimally invasive brain implants for recording neural activity and controlling external devices. | $102.0M | Q4 2024 | Yahoo Finance |
| MintNeuro | Develops low-power semiconductor technology for small and minimally invasive neural implants. | $1.27M | Q4 2024 | Empirical Ventures |
| Nexstem | Builds non-invasive brain-interface hardware, software tools, and real-time brain-signal algorithms. | $3.5M | Q4 2024 | Entrackr |
| INBRAIN Neuroelectronics | Develops graphene brain interfaces that record and stimulate neural activity for disease treatment. | $50.0M | Q4 2024 | Business Wire |
| Neurable | Develops non-invasive brain interfaces that bring EEG controls into everyday consumer products. | $13.0M | Q2 2024 | Business Wire |
| Blackrock Neurotech | Develops implantable brain interfaces for controlling robotic limbs, computers, and digital devices. | $200.0M | Q2 2024 | Blackrock Neurotech |
| SynPhNe | Develops connected rehabilitation wearables that train brain and body functions together. | $5.0M | Q1 2024 | EIN Presswire |
| Elemind | Builds a wearable that reads brainwaves and uses stimulation to guide brain states. | $12.0M | Q1 2024 | Business Wire |
| Motif Neurotech | Develops a miniature brain-stimulation implant for people with treatment-resistant depression. | $18.75M | Q1 2024 | Business Wire |
Related blog posts
- The highest-valued startups in the Brain-Computer interface market
- What does funding activity look like in the Brain-Computer interface market?
- The most heavily funded startups in the Brain-Computer interface market
- What are the key fundraising trends in the Brain-Computer interface market?
